Tempest Therapeutics (TPST) Return on Sales (2015 - 2018)
Tempest Therapeutics (TPST) posted Return on Sales of 1.03% for Q3 2018, down 8.58% sequentially from 0.95% in Q2 2018, and up 64.0% YoY from 0.63% in Q3 2017.
Tempest Therapeutics (TPST) Return on Sales (2015 - 2018) Analysis & Trends
Tempest Therapeutics has reported Return on Sales for 4 years, with the latest figure at 1.03% in Q3 2018.
- Quarterly Return on Sales rose 64.0% year-over-year to 1.03% in Q3 2018, while the trailing twelve-month figure through Sep 2018 was 1.0% (up 101.0% YoY) and the FY2017 annual result came in at 1.73%, down 47.0% from the prior year.
- Return on Sales slipped to 1.03% in Q3 2018 per TPST's latest filing, from 0.95% in the prior quarter.
- Over five years, Return on Sales peaked at 0.94% in Q4 2017 and troughed at 11.47% in Q1 2015.
- A 4-year average of 2.44% and a median of 1.49% in 2016 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2016 and 2017: Return on Sales soared 998 bps in 2016, then sank 118 bps in 2017.
- Over 4 years, Return on Sales stood at 1.31% in 2015, then tumbled by 43 bps to 1.87% in 2016, then soared by 50 bps to 0.94% in 2017, then decreased by 10 bps to 1.03% in 2018.
- According to Business Quant data, Return on Sales over the past three periods registered 1.03%, 0.95%, and 1.1% for Q3 2018, Q2 2018, and Q1 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -1.03% |
| Jun 30, 2018 | -0.95% |
| Mar 31, 2018 | -1.10% |
| Dec 31, 2017 | -0.94% |
| Sep 30, 2017 | -1.67% |
| Jun 30, 2017 | -2.17% |
| Mar 31, 2017 | -2.36% |
| Dec 31, 2016 | -1.87% |
| Sep 30, 2016 | -0.98% |
| Jun 30, 2016 | -0.98% |
| Mar 31, 2016 | -1.49% |
| Dec 31, 2015 | -1.31% |
| Sep 30, 2015 | -2.39% |
| Jun 30, 2015 | -5.83% |
| Mar 31, 2015 | -11.47% |